CyberGene
Solna
About CyberGene
CyberGene develops and sells medical test kits for genetic diagnostics. ChromoQuant® QF PCR kit is a CE marked diagnostic kit for fast detection of chromosome disorders in foetuses. Accompanied with decision support software Visualizer™ enables test time to be reduced from weeks to day/days. CyberGene is also a high quality provider of related products and sevices. The customer base is world wide. The ChromoQuant® product is a family of diagnostic kits for analysing chromosomal disorders. ChromoQuant kits are introduced in several countries worldwide. Find out about ChromoQuant® QF-PCR kit - one of the most widely used CE marked In Vitro Diagnostic kits for prenatal diagnosis on the world market. ChromoQuant AZF - PCR based kit diagnosing microdeletions in the Y chromosome
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Last round: Non-Equity Assistance (Jan 2007)
- Website: cybergene.com
- Phone: +46 8 608 23 90
Industries & Categories
Biotechnology, Genetics, Health Diagnostics, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/cybergene-710180 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.